$186.72
0.12% today
NYSE, Feb 28, 05:15 pm CET
ISIN
US46266C1053
Symbol
IQV

IQVIA Stock price

$186.50
-20.50 9.90% 1M
-62.10 24.98% 6M
-10.01 5.09% YTD
-62.34 25.05% 1Y
-43.62 18.96% 3Y
+43.76 30.66% 5Y
+121.52 187.01% 10Y
NYSE, Closing price Thu, Feb 27 2025
-4.45 2.33%
ISIN
US46266C1053
Symbol
IQV
Sector

Key metrics

Market capitalization $32.84b
Enterprise Value $45.48b
P/E (TTM) P/E ratio 24.88
EV/FCF (TTM) EV/FCF 21.51
EV/Sales (TTM) EV/Sales 2.95
P/S ratio (TTM) P/S ratio 2.13
P/B ratio (TTM) P/B ratio 5.41
Revenue growth (TTM) Revenue growth 2.95%
Revenue (TTM) Revenue $15.41b
EBIT (operating result TTM) EBIT $2.27b
Free Cash Flow (TTM) Free Cash Flow $2.11b
Cash position $1.84b
EPS (TTM) EPS $7.50
P/E forward 24.37
P/S forward 2.07
EV/Sales forward 2.86
Short interest 1.83%
Show more

Is IQVIA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

IQVIA Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a IQVIA forecast:

22x Buy
81%
5x Hold
19%

Analyst Opinions

27 Analysts have issued a IQVIA forecast:

Buy
81%
Hold
19%

Financial data from IQVIA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
15,405 15,405
3% 3%
100%
- Direct Costs 11,144 11,144
3% 3%
72%
4,261 4,261
4% 4%
28%
- Selling and Administrative Expenses 878 878
5% 5%
6%
- Research and Development Expense - -
-
-
3,383 3,383
7% 7%
22%
- Depreciation and Amortization 1,114 1,114
1% 1%
7%
EBIT (Operating Income) EBIT 2,269 2,269
11% 11%
15%
Net Profit 1,373 1,373
1% 1%
9%

In millions USD.

Don't miss a Thing! We will send you all news about IQVIA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IQVIA Stock News

Neutral
Business Wire
3 days ago
UPPER NYACK, N.Y.--(BUSINESS WIRE)--When pharmacists can't give adult vaccinations, millions of people go without them.
Neutral
Business Wire
4 days ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences and healthcare industries, today announced that IQVIA AI Assistant has been awarded a 2024 PM360 Innovation Award in the Artificial Intelligence category. Launched in September 2024, IQVIA AI Assistant revoluti...
Neutral
Business Wire
7 days ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the TD Cowen Annual Health Care Conference on Tuesday, March 4, 2025, at 11:10 a.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia...
More IQVIA News

Company Profile

Provides biopharmaceutical development services and commercial outsourcing services

Head office United States
CEO Ari Bousbib
Employees 88,000
Founded 1950
Website www.iqvia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today